Majically, the Board has now found $20m in annualised savings to be extracted in Pathology; it took a a few slaps, in loss of bowel screening contract and wages reset cost increase, for them to come to their senses.
Knife to costs has been argued here as essential for well over 24 months.
Afraid too little, too late.
Majically, the Board has now found $20m in annualised savings to...
Add HLS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.32 |
Change
-0.025(1.87%) |
Mkt cap ! $1.212B | |||
| Open | High | Low | Value | Volume |
| $1.35 | $1.36 | $1.30 | $3.748M | 2.841M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 11309 | $1.32 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.32 | 26313 | 2 |
View Market Depth
| Last trade - 16.10pm 21/11/2024 (20 minute delay) ? |
| HLS (ASX) Chart |
